The median age at diagnosis and the end of the study was 13 (range 1-84) and 82 (range 16-248) months, respectively. Three splenectomised and one non-splenectomised patients died during the total observation period of 436 group.bmj.com on April 9, 2017 -Published by http://adc.bmj.com/ Downloaded from
The Wiskott-Aldrich syndrome is a rare X linked disease characterised by thrombocytopenia, eczema, and increased susceptibility to infections. 
Results
The median age at diagnosis and the end of the study was 13 (range 1-84) and 82 (range 16-248) months, respectively. Three splenectomised and one non-splenectomised patients died during the total observation period of 0.004, CI 0.5 to 1.7 fl) compared with values before splenectomy. Limited but clinically useful increases in platelet numbers occurred after IVIG (0.4-2.0 g/kg/day for one to five days) in two of seven patients before splenectomy. Each had evidence of autoimmune disease (positivity of platelet associated immunoglobulin in one, vasculitis in the other); one of them also received corticosteroid treatment for vasculitis. Sustained resolution of thrombocytopenia was also achieved with high dose IVIG in one patient after splenectomy.
Fourteen of a total of 18 episodes of severe acute bacterial infection involved the lung. The other severe infection was an episode of Pneumocystis carinii pneumonia in a patient receiving immunosuppressive treatment. The rate of severe acute bacterial infection before splenectomy was 0.10 per annum (14 in 1754 patient months) and after splenectomy 0.11 (four in 451 patient months).
Symptoms of significant chronic lung disease started before splenectomy in two patients. Lobectomy for aspergillus (two) and actinomycosis (one) was performed 4-15 months after splenectomy. Frequent herpes simplex exacerbations (three), extensive Molluscum contagiosum (three), and chronic multifocal leucoencephalopathy affected the five patients with significant chronic viral infection. immunodeficiency."32' It is encouraging that there were only four episodes of severe acute bacterial infection in our group in 451 patient months after splenectomy; this may be associated with the use of IVIG together with antibiotic prophylaxis. Immunoglobulin replacement is a rational form of treatment in Wiskott-Aldrich syndrome in view of the disturbed antibody production,2425 but no controlled clinical trials evaluating the efficacy of IVIG or antibiotic prophylaxis in WiskottAldrich syndrome have been performed or are likely because of the rarity of the disorder.
Eighty one per cent of patients were alive at a median age of 82 months. Most had a good quality of life, however longer follow up is required to establish whether this comparatively good survival rate will be sustained. Fewer deaths from haemorrhage can be anticipated and the combination of IVIG, penicillin, and co-trimoxazole may be adequate in preventing postsplenectomy sepsis. Three patients died after splenectomy and three others developed allergic or autoimmune symptoms requiring high levels of immunosuppression. These problems were probably not related to splenectomy but indicate that BMT should be carried out at an early stage if a related, or possibly an unrelated, HIA identical donor is available.
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